This Article Full Text (PDF) All Versions of this Article: 36/10/2321    most recent 01.STR.0000179041.80222.dcv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kase, C. S. Search for Related Content PubMed PubMed Citation Articles by Kase, C. S. Pubmed/NCBI databases Substance via MeSH

Submitted on June 22, 2005
Accepted on July 13, 2005

Hemostatic Treatment in the Early Stage of Intracerebral Hemorrhage. The Recombinant Factor VIIa Experience

From the Department of Neurology, Boston University School of Medicine, Boston, Mass.

^* To whom correspondence should be addressed. E-mail: cskase{at}bu.edu.

This article has been cited by other articles:

				J. D. Sturgeon, A. R. Folsom, W.T. Longstreth Jr, E. Shahar, W. D. Rosamond, and M. Cushman Hemostatic and Inflammatory Risk Factors for Intracerebral Hemorrhage in a Pooled Cohort Stroke, August 1, 2008; 39(8): 2268 - 2273. [Abstract] [Full Text] [PDF]

				W. K. Hoots Challenges in the Therapeutic Use of a "So-Called" Universal Hemostatic Agent: Recombinant Factor VIIa Hematology, January 1, 2006; 2006(1): 426 - 431. [Abstract] [Full Text] [PDF]